RAB7A and type 2 diabetes mellitus: Furthermore, our data demonstrates that inhibition of Rab7a can be used to enhance beta cell growth factor responsiveness and to promote islet survival under conditions of metabolic stress relevant to the conditions that occur in many people with type 2 diabetes.